Numerous studies have shown that nonsteroidal anti-inflammatory drugs (NSAIDs), which are COX-2 inhibitors, reduce the risk of developing Alzheimer’s disease and enhance learning and memory [23,24]. The gene discussed is PTGS2; the disease is Alzheimer disease.